We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
American Well (AMWL) Surges 6.1%: Is This an Indication of Further Gains?
Read MoreHide Full Article
American Well Corporation (AMWL - Free Report) shares ended the last trading session 6.1% higher at $14.98. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 4% gain over the past four weeks.
American Well scored a strong price increase on investors’ optimism surrounding the company’s impending third quarter 2026 financial results, which is expected to release on Nov. 3, after the closing bell. The Zacks Consensus Estimate for the third quarter revenue suggests a decline of 16.4% and the loss per share is expected to improve 62.1%.
This company is expected to post quarterly loss of $0.66 per share in its upcoming report, which represents a year-over-year change of +62.1%. Revenues are expected to be $47.06 million, down 16.4% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For American Well, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on AMWL going forward to see if this recent jump can turn into more strength down the road.
American Well is a member of the Zacks Medical Info Systems industry. One other stock in the same industry, Evolent Health (EVH - Free Report) , finished the last trading session 1.9% lower at $4.25. EVH has returned 24.1% over the past month.
Evolent Health's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.06. Compared to the company's year-ago EPS, this represents a change of +20%. Evolent Health currently boasts a Zacks Rank of #3 (Hold).
View the Zacks #1 Rank List
Image: Bigstock
American Well (AMWL) Surges 6.1%: Is This an Indication of Further Gains?
American Well Corporation (AMWL - Free Report) shares ended the last trading session 6.1% higher at $14.98. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 4% gain over the past four weeks.
American Well scored a strong price increase on investors’ optimism surrounding the company’s impending third quarter 2026 financial results, which is expected to release on Nov. 3, after the closing bell. The Zacks Consensus Estimate for the third quarter revenue suggests a decline of 16.4% and the loss per share is expected to improve 62.1%.
This company is expected to post quarterly loss of $0.66 per share in its upcoming report, which represents a year-over-year change of +62.1%. Revenues are expected to be $47.06 million, down 16.4% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For American Well, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on AMWL going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
American Well is a member of the Zacks Medical Info Systems industry. One other stock in the same industry, Evolent Health (EVH - Free Report) , finished the last trading session 1.9% lower at $4.25. EVH has returned 24.1% over the past month.
Evolent Health's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.06. Compared to the company's year-ago EPS, this represents a change of +20%. Evolent Health currently boasts a Zacks Rank of #3 (Hold).